| Literature DB >> 28930252 |
Abstract
Qigong is an internal art practice with a long history in China. It is currently characterized as meditative movement (or as movement-based embodied contemplative practice), but is also considered as complementary and alternative exercise or mind-body therapy. There are now six controlled trials and nine other reports on the effects of qigong in fibromyalgia. Outcomes are related to amount of practice so it is important to consider this factor in overview analyses. If one considers the 4 trials (201 subjects) that involve diligent practice (30-45 min daily, 6-8 weeks), there are consistent benefits in pain, sleep, impact, and physical and mental function following the regimen, with benefits maintained at 4-6 months. Effect sizes are consistently in the large range. There are also reports of even more extensive practice of qigong for 1-3 years, even up to a decade, indicating marked benefits in other health areas beyond core domains for fibromyalgia. While the latter reports involve a limited number of subjects and represent a self-selected population, the marked health benefits that occur are noteworthy. Qigong merits further study as a complementary practice for those with fibromyalgia. Current treatment guidelines do not consider amount of practice, and usually make indeterminate recommendations.Entities:
Keywords: fibromyalgia; pain; qigong
Year: 2017 PMID: 28930252 PMCID: PMC5590073 DOI: 10.3390/medicines4020037
Source DB: PubMed Journal: Medicines (Basel) ISSN: 2305-6320
Characterization of qigong within recent reviews and overviews of treatments for fibromyalgia (FM).
| Characterization of Qigong | Reference | Comments, Conclusions |
|---|---|---|
| (1) Meditative Movement for FM (systematic review, meta-analysis) | Langhorst et al., 2013 [ | Did not include any 2012 qigong RCTs; effect sizes in medium range; concluded high quality trials needed |
| (2) Qigong for FM (systematic review, meta-analysis) | Lauche et al., 2013 [ | Considered N = 6 RCTs of qigong for FM; concluded qigong may be useful, but recommendation regarded as weak based on trial quality |
| (3) Complementary and Alternative Exercise for FM (meta-analysis) | Mist et al., 2013 [ | Noted medium-to-large effect sizes; concluded little risk in recommending as component of multimodal treatment |
| (4) Qigong for FM (review) | Sawynok, Lynch 2014 [ | RCTs involving daily practice for 6–8 weeks show consistent medium-to-large effect sizes in core domains, with benefits sustained at 4–6 months; concluded qigong merits continued exploration for FM |
| (5) Mind–body therapies for FM (as part of rheumatic diseases) (review) | Del Rosso, Maddali 2016 [ | Notes variable results in 4 RCTs in FM (one in children); did not cite 2 adult RCTs from 2012; concluded mind–body therapies useful for overall health in rheumatic diseases |
NOTE: Between 2003 and 2012, six controlled RCTs of qigong for FM in adults were published [17,18,19,20,21,22]; these originated at different sites (USA, Sweden, Canada, Italy) and reflect different forms of qigong and different regimens of practice. Four RCTs involved daily practice of qigong for 6–8 weeks [19,20,21,22]. Some reviews and analyses include a pilot study of external qigong [23], a study in children [24], and studies where qigong was part of multi-component treatment and no daily practice was involved [17,18].
Summary of randomized controlled trials (RCTs) of qigong for fibromyalgia in adults.
| Study Characteristics | Outcomes, Features |
|---|---|
| (1) Astin et al., 2003 [ | Outcomes: B, 8 wks, 4 mos, 6 mos |
| (2) Mannerkorpi, Arndow 2004 [ | Outcomes: B, 3 mos |
| (3) Haak, Scott (2008) [ | Outcomes: B, 8 wks, 4 mos |
| (4) Liu et al., 2012 [ | Outcomes: B, 6 wks |
| (5) Lynch et al., 2012 [ | Outcomes: B, 8wks, 4 mos, 6 mos |
| (6) Maddali Bongi et al., 2012 [ | Outcomes: B, 7 wks, 15 wks, 6 mos |
Note: Trials summarized in table used 1990 FM criteria. Abbreviations: B, baseline; FIQ, fibromyalgia impact questionnaire; h, hours; min, minutes; mos, months; NS, non-significant (p > 0.05); wks, weeks; yrs, years.
Summary of other studies of qigong for fibromyalgia.
| Study Characteristics | Outcomes, Features |
|---|---|
| (1) Creamer et al., 2000 [ | B, 8 wks, 4 mos, 6 mos |
| (2) Chen et al., 2006 [ | B, 3 wks, 1 mo, 3 mo |
| (3) Lynch et al., 2009 [ | B, 9 wks, 3 mos, 6 mos |
| (4) Sawynok et al., 2013 [ | Quantitative: For N = 13 who completed extension, significant within-group improvements in pain, FIQ, sleep and function; 5/13 had voluntarily continued with community practice following the RCT and reported practicing 10–15 h/wk |
| (5) Sawynok et al., 2013 [ | Case 1: initial improvements in pain, tension, anxiety, food sensitivities, blood pressure; 12 mos: medications and supplements discontinued; 3 yrs: minimal pain (occasional, local), headaches gone, cognition, sleep, fatigue, mood, skin and circulation all improved |
| (6) Sawynok and Lynch 2014 [ | Narrative: There was a difference in initial experiences (over 6 mos) with qigong by those who completed the extension trial (N = 13) vs. those who did not complete (N = 7); comments recapitulate quantitative domain measures, but also cover other areas |
| (7) Sawynok 2016 [ | Case 1: Commenced qigong in 2008; had FM with multiple issues, all of which resolved over time; currently takes no medications; improvements in vision occured gradually over time (acuity changes 1.5–1.75) |
Note: Trials summarized in this table generally used 1990 FM criteria. However, the onset of FM in several case reports predates 1990, and the condition was a clinical diagnosis rather than a research diagnosis. Abbreviations: B: baseline; CFQ: Chaoyi Fanhuan Qigong; FIQ: fibromyalgia impact questionnaire; h: hours; mos: months; wks: weeks; yrs: years.